HAMBURG (dpa-AFX) - Biotech company Evotec is getting a new chief financial officer. Laetitia Rouxel will take over as chief financial officer effective April 1, the MDax company announced Tuesday in Hamburg. She succeeds Enno Spillner, whose contract expires at the end of March and who will move on to new tasks. Rouxel reportedly has more than 25 years of financial experience in various industries, including life sciences, nutrition, cosmetics and the construction sector. She has worked for pharmaceutical company Pfizer, food company Danone and cosmetics company Coty, among others, it said./mis/jha/.